Poly(ADP-ribose) polymerases: Homology, structural domains and functions. Novel therapeutical applications

Progress in Biophysics and Molecular Biology

Volumn 88, Issue 1, 2005, Pages 143-172

  Nguewa, Paul A ^a   Fuertes, Miguel A ^b   Valladares, Basilio ^a   Alonso, Carlos ^b   Pérez, José M ^b  

^a UNIVERSIDAD DE LA LAGUNA   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Functions; Location; New therapies; PARP polymerases; Structure

Indexed keywords

ENZYME INHIBITOR; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;

CELL DEATH; DNA DAMAGE; DNA REPAIR; DRUG ANTAGONISM; HUMAN; METABOLISM; NEOPLASM; NEUROLOGIC DISEASE; PHYSIOLOGY; REVIEW;

CELL DEATH; DNA DAMAGE; DNA REPAIR; ENZYME INHIBITORS; HUMANS; NEOPLASMS; NERVOUS SYSTEM DISEASES; POLY(ADP-RIBOSE) POLYMERASES;

EID: 9244227657     PISSN: 00796107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbiomolbio.2004.01.001     Document Type: Review

References (147)

1. Affar E.B., Germain M., Winstall E., Vodenicharov M., Shah R.G., Salvesen G.S., Poirier G.G Caspase-3-mediated processing of poly(ADP-ribose) glycohydrolase during apoptosis. J. Biol. Chem. 276:2001;2935-2942
2. Althaus F.R., Hofferer L., Kleczkowska H.E., Malanga M., Naegeli H., Panzeter P., Realini C. Histone shuttle driven by the automodification cycle of poly(ADP-Ribose) polymerase. Environ. Mol. Mutagen. 22:1993;278-282
3. Althaus F.R., Kleczkowska H.E., Malanga M., et al. Poly ADP-ribosylation. a DNA break signal mechanism Mol. Cell Biochem. 193:1999;5-11
4. Ame J.C., Rolli V., Schreiber V., Niedergang C., Apiou F., Decker P., Muller S., Hoger T., Menissier de Murcia J., de Murcia G. PARP-2, a novel mammalian DNA damage-dependent poly(ADP-ribose) polymerase. J. Biol. Chem. 274:1999;17860-17868
5. Augustin A., Spenlehauer C., Dumond H., Menissier de Murcia J., Piel M., Schmit A.C., Apiou F., Vonesch J.L., Kock M., Bornens M., de Murcia G. PARP-3 localizes preferentially to the daughter centriole and interferes with the G1/S cell cycle progression. J. Cell Sci. 116:2003;1551-1562
6. Benchoua A., Couriaud C., Guegan C., Tartier L., Couvert P., Friocourt G., Chelly J., Menissier de Murcia J., Onteniente B. Active caspase-8 translocates into the nucleus of apoptotic cells to inactivate poly(ADP-ribose) polymerase-2. J. Biol. Chem. 277:2002;34217-34222
7. Berger N.A., Sims J.L., Catino D.M., Berger S.J. Poly(ADP-ribose) polymerase mediates the suicide response to massive DNA damage. studies in normal and DNA-repair defective cells Princess Takamatsu Symp. 13:1983;219-226
8. Berger S.J., Sudar D.C., Berger N.A. Metabolic consequences of DNA damage. DNA damage induces alterations in glucose metabolism by activation of poly(ADP-ribose) polymerase Biochem. Biophys. Res. Commun. 134:1986;227-232
9. Bianchi A., Smith S., Chong L., Elias P., de Lange T. TRF1 is a dimer and bends telomeric DNA. EMBO J. 16:1997;1785-1794
10. Bilaud T., Brun C., Ancelin K., Koering C.E., Laroche T., Gilson E. Telomeric localization of TRF2, a novel human telobox protein. Nat. Genet. 17:1997;236-239
11. Bonfoco E., Krainc D., Ankarcrona M., Nicotera P., Lipton S.A. Apoptosis and necrosis. two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures Proc. Nat. Acad. Sci. USA. 92:1995;7162-7166
12. Bork P., Hofmann K., Bucher P., Neuwald A.F., Altschul S.F., Koonin E.V. A superfamily of conserved domains in DNA damage-responsive cell cycle checkpoint proteins. FASEB J. 11:1997;68-76
13. Boulikas T. Poly(ADP-ribosylated) histones in chromatin replication. J. Biol. Chem. 265:1990;14638-14647
14. Bowman K.J., White A., Golding B.T., Griffin R.J., Curtin N.J. Potentiation of anti-cancer agent cytotoxicity by the potent poly(ADP-ribose) polymerase inhibitors NU1025 and NU1064. Br. J. Cancer. 78:1998;1269-1277
15. Brinkley B.R. Managing the centrosome numbers game. from chaos to stability in cancer cell division Trends Cell Biol. 61:2001;13-34
16. Broccoli D., Smogorzewska A., Chong L., de Lange T. Human telomeres contain two distinct Myb-related proteins, TRF1 and TRF2. Nat. Genet. 17:1997;231-235
17. Brochu G., Duchaine C., Thibeault L., Lagueux J., Shah G.M., Poirier G.G. Mode of action of poly(ADP-ribose) glycohydrolase. Biochim. Biophys. Acta. 1219:1994;342-350
18. Brown J.A., Marala R.B. Development of a high-throughput screening-amenable assay for human poly(ADP-ribose) polymerase inhibitors. J. Pharmacol. Toxicol. Methods. 47:2002;137-141
19. Burkle A. Physiology and pathophysiology of poly(ADP-ribosyl)ation. Bioessays. 23:2001;795-806
20. Bürkle A. PARP-1. a regulator of genomic stability linked with mammalian longevity ChemBioChem. 2:2001;725-728
21. Callebaut I., Mornon J.P. From BRCA1 to RAP1. a widespread BRCT module closely associated with DNA repair FEBS Lett. 400:1997;25-30
22. Cesarone C.F., Scarabelli L., Scovassi I., Izzo R., Menegazzi M., DePrati A.C., Orunesu M., Bertazzoni U. Changes in activity and mRNA levels of poly(ADP-ribose)polymerase during rat liver regeneration. Biochim. Biophys. Acta. 1087:1990;241-246
23. Chatterjee S., Berger S.J., Berger N.A. Poly(ADP-ribose) polymerase. a guardian of the genome that facilitates DNA repair by protecting against DNA recombination Mol. Cell Biochem. 193:1999;23-30
24. Chi N.W., Lodish H.F. Tankyrase is a golgi-associated mitogen-activated protein (MAP) kinase substrate that interacts with IRAP in GLUT4 vesicles. J. Biol. Chem. 275:2000;38437-38444
25. Choi-Miura N.H., Sano Y., Oda E., Nakano Y., Tobe T., Yanagishita T., Taniyama M., Katagiri T., Tomita M. Purification and characterization of a novel glycoprotein which has significant homology to heavy chains of inter-alpha-trypsin inhibitor family from human plasma. J. Biochem. 117:1995;400-407
26. Chong L., van Steensel B., Broccoli D., Erdjument-Bromage H., Hanish J., Tempst P., de Lange T. A human telomeric protein. Science. 270:1995;1663-1667
27. Chugani D.C., Rome L.H., Kedersha N.L. Evidence that vault ribonucleoprotein particles localize to the nuclear pore complex. J. Cell Sci. 106:1993;23-29
28. Ciftci O., Ullrich O., Schmidt C.A., Diestel A., Hass R. Regulation of the nuclear proteasome activity in myelomonocytic human leukemia cells after adriamycin treatment. Blood. 97:2001;2830-2838
29. Collins K. Mammalian telomeres and telomerase. Curr. Opin. Cell Biol. 12:2000;378-383
30. Cook B.D., Dynek J.N., Chang W., Shostak G., Smith S. Role for the related poly(ADP-ribose) polymerases tankyrase 1 and 2 at human telomeres. Mol. Cell Biol. 22:2002;332-342
31. d'Adda di Fagagna F., Hande M.P., Tong W.M., Lansdorp P.M., Wang Z.Q., Jackson S.P. Functions of poly(ADP-ribose) polymerase in controlling telomere length and chromosomal stability. Nat. Genet. 23:1999;76-80
32. D'Amours D., Desnoyers S., D'Silva I., Poirier G.G. Poly(ADP-ribosyl) ation reactions in the regulation of nuclear functions. Biochem. J. 342:1999;249-268
33. D'Amours D., Sallmann F.R., Dixit V.M., Poirier G.G. Gain-of-function of poly(ADP-ribose) polymerase-1 upon cleavage by apoptotic proteases. implications for apoptosis J. Cell Sci. 114:2001;3771-3778
34. Dantzer F., Schreiber V., Niedergang C., et al. Involvement of poly(ADP-ribose)polymerase in base excision repair. Biochimie. 81:1999;69-75
35. Davidovic L., Vodenicharov M., Affar E.B., Poirier G.G. Importance of poly(ADP-ribose) glycohydrolase in the control of poly(ADP-ribose) metabolism. Exp. Cell Res. 268:2001;7-13
36. de Murcia G., Menissier de Murcia J. Poly(ADP-ribose) polymerase. a molecular nick-sensor Trends Biochem. Sci. 19:1994;172-176
37. de Murcia G., Schreiber V., Molinete M., Saulier B., Poch O., Masson M., Niedergang C., Menissier de Murcia J. Structure and function of poly(ADP-ribose) polymerase. Mol. Cell Biochem. 138:1994;15-24
38. de Murcia J.M., Niedergang C., Trucco C., Ricoul M., Dutrillaux B., Mark M., Oliver F.J., Masson M., Dierich A., LeMeur M., et al. Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells. Proc. Nat. Acad. Sci. USA. 94:1997;7303-7307
39. + depletion and cell death induced by oxidative stress. J. Biol. Chem. 278:2003;18426-18433
40. Doxsey S. The centrosome-a tiny organelle with big potential. Nat. Genet. 20:1998;104-106
41. Endres M., Scott G., Namura S., Salzman A.L., Huang P.L., Moskowitz M.A., Szabó C. Role of peroxynitrite and neuronal nitric oxide synthase in the activation of poly(ADP-ribose) synthetase in a murine model of cerebral ischemiareperfusion. Neurosci. Lett. 248:1998;41-44
42. Farber J.L., Kyle M.E., Coleman J.B. Mechanisms of cell injury by activated oxygen species. Lab. Invest. 62:1990;670-679
43. Farkas B., Magyarlaki M., Csete B., Nemeth J., Rabloczky G., Bernath S., Literati Nagy P., Sumegi B. Reduction of acute photodamage in skin by topical application of a novel PARP inhibitor. Biochem. Pharmacol. 63:2002;921-932
44. Faro R., Toyoda Y., McCully J., Jagtap P., Szabó E., Virag L., Bianchi C., Levitsky S., Szabó C. Protective effect on regional myocardial function and infarct size induced by PJ34. a novel poly (ADP-ribose) synthetase inhibitor Ann. Thorac. Surg. 73:2002;575-581
45. Ferro A.M., Olivera B.M. Poly(ADP-ribosyl)ation of DNA topoisomerase I from calf thymus. J. Biol. Chem. 259:1984;547-554
46. Fiorillo C., Pace S., Ponziani V., Nediani C., Perna A.M., Liguori P., Cecchi C., Nassi N., Donzelli G.P., Formigli L., et al. Poly(ADP-ribose) polymerase activation and cell injury in the course of rat heart heterotopic transplantation. Free Radical Res. 36:2002;79-87
47. Fuertes M.A., Alonso C., Pérez J.M. Biochemical modulation of cisplatin mechanisms of action. enhancement of antitumor activity and circumvention of drug resistance Chem. Rev. 103:2003;645-663
48. Fuertes M.A., Castilla J., Alonso C., Pérez J.M. Cisplatin biochemical mechanism of action. from cytotoxicity to induction of cell death through interconnections between apoptotic and necrotic pathways Curr. Med. Chem. 10:2003;257-266
49. Fukasawa K., Choi T., Kuriyama R., Rulong S., Vande Woude G.F. Abnormal centrosome amplification in the absence of p53. Science. 271:1996;1744-1747
50. Furlini G., Ripalti A., Landini M.P., La Placa M. Increased levels of ADP ribosylation during cytomegalovirus replication in human embryo fibroblasts. Microbiologica. 7:1984;279-285
51. Goldfarb R.H., Marton A., Szabó E., Virag L., Glock D., McCarthy R., Parillo J.E., Szabó C. Protective effect of a novel, potent inhibitor of poly (ADP-ribose) synthetase in a porcine model of severe bacterial sepsis. Crit. Care Med. 30:2002;974-980
52. Greider C.W., Blackburn E.H. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell. 43:1985;405-413
53. Griffith J., Bianchi A., de Lange T. TRF1 promotes parallel pairing of telomeric tracts in vitro. J. Mol. Biol. 278:1998;79-88
54. Griffith J.D., Comeau L., Rosenfield S., Stansel R.M., Bianchi A., Moss H., de Lange T. Mammalian telomeres end in a large duplex loop. Cell. 97:1999;503-514
55. Ha H.C., Snyder S.H. Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc. Nat. Acad. Sci. USA. 96:1999;13978-13982
56. Ha H.C., Juluri K., Zhou Y., Leung S., Hermankova M., Snyder S.H. Poly(ADP-ribose) polymerase-1 is required for efficient HIV-1 integration. Proc. Nat. Acad. Sci. USA. 98:2001;3364-3368
57. Hanawalt P.C., Donahue B.A., Sweder K.S. Collision or collusion. Curr. Biol. 4:1994;518-521
58. Hatekayama K., Nemoto Y., Ueda Y., Hayashi O. Purification and characterization of poly(ADP-ribose) glycohydrolase. Different modes of action on large and small poly(ADP-ribose). J. Biol. Chem. 261:1986;14902-14911
59. Hauschildt S., Scheipers P., Bessler W.G., Mulsch A. Induction of nitric oxide synthase in L929 cells by tumour-necrosis factor alpha is prevented by inhibitors of poly(ADP-ribose) polymerase. Biochem. J. 288:1992;255-600
60. Homburg S., Visochek L., Moran N., Dantzer F., Priel E., Asculai E., Schwartz D., Rotter V., Dekel N., Cohen-Armon M. A fast signal-induced activation of poly(ADP-ribose) polymerase. a novel downstream target of phospholipase C J. Cell Biol. 150:2000;293-307
61. Jagtap P., Soriano F.G., Virag L., Liaudet L., Mabley J., Szabó E., Hasko G., Marton A., Lorigados C.B., Gallyas F., et al. Novel phenanthridinone inhibitors of poly(ADP-ribose) synthetase. potent cytoprotective and anti-shock agents Crit. Care Med. 30:2002;1071-1082
62. Jonsson G.G., Jacobson E.L., Jacobson M.K. Mechanism of alteration of poly(adenosine diphosphate-ribose) metabolism by hyperthermia. Cancer Res. 48:1988;4233-4239
63. Jonsson G.G., Menard L., Jacobson E.L., Poirier G.G., Jacobson M.K. Effect of hyperthermia on poly(adenosine diphosphate-ribose) glycohydrolase. Cancer Res. 48:1988;4240-4243
64. Kaminker P.G., Kim S.H., Taylor R.D., Zebarjadian Y., Funk W.D., Morin G.B., Yaswen P., Campisi J. TANK2, a new TRF1-associated poly(ADP-ribose) polymerase, causes rapid induction of cell death upon overexpression. J. Biol. Chem. 276:2001;35891-35899
65. Kanai M., Uchida M., Hanai S., Uematsu N., Uchida K., Miwa M. Poly(ADP-ribose) localizes to the centrosomes and chromosomes. Biochem. Biophys. Res. Commun. 278:2000;385-389
66. Kasid U.N., Halligan B., Liu L.F., Dritschilo A., Smulson M. Poly(ADP-ribose)-mediated post-translational modification of chromatinassociated human topoisomerase-I. inhibitory effects on catalytic activity J. Biol. Chem. 264:1989;18687-18692
67. Keith G., Desgrès J., de Murcia G. Use of two-dimensional thin-layer chromatography for components study of poly(adenosine diphosphate ribose). Anal. Biochem. 191:1990;309-313
68. Kickhoefer V.A., Siva A.C., Kedersha N.L., Inman E.M., Ruland C., Streuli M., Rome L.H. The 193-KD vault protein, VPARP, is a novel poly(ADP-ribose) polymerase. J. Cell Biol. 146:1999;917-928
69. Kleczkowska H.E., Althaus F.R. The role of poly(ADP-ribosyl)ation in the adaptive response. Mutat Res. 358:1996;215-221
70. Kuimov A.N., Kuprash D.V., Petrov V.N., Vdovichenko K.K., Scanlan M.J., Jongeneel C.V., Lagarkova M.A., Nedospasov S.A. Cloning and characterization of TNKL, a member of tankyrase gene family. Genes Immun. 2:2001;52-55
71. La Placa M.C., Zhang J., Raghupathi R., Li J.H., Smith F., Bareyre F.M., Snyder S.H., Graham D.I., McIntosh T.K. Pharmacologic inhibition of poly(ADP-ribose) polymerase is neuroprotective following traumatic brain injury in rats. J. Neurotrauma. 18:2001;369-376
72. Lautier D., Lagueux J., Thibodeau J., Menard L., Poirier G.G. Molecular and biochemical features of poly(ADP-ribose) metabolism. Mol. Cell Biochem. 122:1993;171-193
73. Lazebnik Y.A., Kaufmann S.H., Desnoyers S., Poirier G.G., Earnshaw W.C. Cleavage of poly(ADP-ribose)polymerase by a proteinase with properties like ICE. Nature. 371:1994;346-347
74. Le Page C., Sanceau J., Drapier J.C., Wietzerbin J. Inhibitors of ADP ribosylation impair inducible nitric oxide synthase gene transcription through inhibition of NF kappa B activation. Biochem. Biophys. Res. Commun. 243:1998;451-457
75. Liaudet L., Soriano F.G., Szabó C. Poly(ADP-ribose) synthetase, as a novel therapeutic target for shock. Vincent J.L. Yearbook of Intensive Care and Emergency Medicine. 2001;78-89 Springer, Heidelberg, Germany
76. Lin W., Ame J.C., Aboul-Ela N., Jacobson E.L., Jacobson M.K. Isolation and characterization of the cDNA encoding bovine poly(ADP-ribose) glycohydrolase. J. Biol. Chem. 272:1997;11895-11901
77. Lindahl T., Satoh M.S., Poirier G.G., Klungland A. Post-translational modification of poly(ADP-ribose) polymerase induced by DNA strand breaks. Trends. Biochem. Sci. 20:1995;405-411
78. Li Oei S., Griesenbeck J., Scheiger M., Ziegler M. Regulation of RNA polymerase II-dependent transcription by poly(ADP-ribosyl)ation of transcription factors. J. Biol. Chem. 273:1998;31644-31647
79. Lyons R.J., Deane R., Lynch D.K., Ye Z.S., Sanderson G.M., Eyre H.J., Sutherland G.R., Daly R.J. Identification of a novel human Tankyrase through its interaction with the adapter protein Grb14. J. Biol. Chem. 22:2001;17172-17180
80. Marsischky G.T., Wilson B.A., Collier R.J. Role of glutamic acid 988 of human poly(ADP-ribose) polymerase in polymer formation. Evidence for active site similarities to the ADP-ribosylating toxins. J. Biol. Chem. 270:1995;3247-3255
81. Martinou J.C. ICE-like proteases execute the neuronal death program. Curr. Opin. Neurosci. 6:1996;609-614
82. n catabolism in DNA repair. Biochem. Biophys. Res. Commun. 236:1997;265-269
83. Masson M., Rolli V., Dantzer F., Trucco C., Schreiber V., Fribourg S., Molinete M., Ruf A., Alves Miranda E., Niedergang C., Hunting D., Gowans B., Schulz G.E., Ménissier de Murcia J., de Murcia G. Biochimie. 77:1995;456-461
84. Meisterernst M., Stelzer G., Roeder R.G. Poly(ADP-ribose)polymerase enhances activator-dependent transcription in vitro. Proc. Nat. Acad. Sci. USA. 94:1997;2261-2265
85. Mendeleyev J., Kirsten E., Kaham A., Buki K.G., Kun E. Potential chemotherapeutic of 4-iodo-3-nitrobenzamida. Metabolic reduction to the 3-nitroso derivatives and induction of cell death in tumor cells in culture. Biochem. Pharmacol. 50:1995;705-714
86. Miyamoto T., Kakizawa T., Hashizume K. Inhibition of nuclear receptor signalling by poly(ADP-ribose) polymerase. Mol. Cell Biol. 19:1999;2644-2649
87. Monz D., Munnia A., Comtesse N., Fischer U., Steudel W.I., Feiden W., Glass B., Meese E.U. Novel tankyrase-related gene detected with meningioma-specific sera. Clin. Cancer Res. 7:2001;113-119
88. Nguewa P.A., Fuertes M.A., Alonso C., Pérez J.M. Pharmacological modulation of poly(ADP-ribose) polymerase-mediated cell death. exploitation in cancer chemotherapy Mol. Pharmacol. 64:2003;1007-1014
89. Nicholson D.W., Ali A., Thornberry N.A., Vaillancourt J.P., Ding C.K., Gallant M., Gareau Y., Lazebnik Y.A., Raju S.M., Smulson M.E., et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature. 376:1995;37-43
90. Nicotera P., Leist M., Ferrando-May E. Apoptosis and necrosis. different execution of the same death Biochem. Soc. Symp. 66:1999;69-73
91. Nugent C.I., Lundblad V. The telomerase reverse transcriptase. components and regulation Genes Dev. 12:1998;1073-1085
92. Oei S.L., Ziegler M. ATP for the DNA ligation step in base excision repair is generated from poly(ADP-ribose). J. Biol. Chem. 275:2000;23234-23239
93. Oka J., Ueda K., Hayaishi O., Komura H., Nakanishi K. ADP-ribosyl protein lyase. Purification, properties and identification of the product. J. Biol. Chem. 259:1984;986-995
94. Oliver F.J., de la Rubia G., Rolli V., Ruiz-Ruiz M.C., de Murcia G., Menissier de Murcia J. Importance of poly(ADP-ribose) polymerase and its cleavage in apoptosis. J. Biol. Chem. 273:1998;33533-33539
95. Oliver F.J., Menissier de Murcia J., Nacci C., Decker P., Andriantsitohaina R., Muller S., de la Rubia G., Stoclet J.C., de Murcia G. Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice. EMBO (Eur. Mol. Biol. Organ) J. 18:1999;4446-4454
96. Otsuka A., Hanafusa T., Miyagawa J., Kono N., Tarui S. Nicotinamide and 3-aminobenzamide reduce interferon-gamma-induced class II MHC (HLA-DR and -DP) molecule expression on cultured human endothelial cells and fibroblasts. Immunopharmacol. Immunotoxicol. 13:1991;263-280
97. Pacher P., Liaudet L., Soriano F.G., Mabley J., Szabó E., Szabó C. The role of poly(ADP-ribose) polymerase in the development of myocardial and endothelial dysfunction in diabetes mellitus. Diabetes. 51:2002;514-521
98. Perrin D., Gras S., van Hille B., Hill B.T. Expression in yeast and purification of functional recombinant human poly(ADP-ribose) polymerase (PARP). Comparative pharmacological profile with that of the rat enzyme. J. Enzyme Inhib. 15:2000;461-469
99. Pihan G.A., Purohit A., Wallace J., Knecht H., Woda B., Quesenberry P., Doxsey S.J. Centrosome defects and genetic instability in malignant tumors. Cancer Res. 58:1998;3974-3985
100. Pleschke J.M., Kleczkowska H.E., Strohm M., Althaus F.R. Poly(ADP-ribose) binds to specific domains in DNA damage checkpoint proteins. J. Biol. Chem. 275:2000;40974-40980
101. Rawling J.M., Alvarez-Gonzalez A. TFIIF, a basal eukaryotic transcription factor, is a substrate for poly(ADP-ribosyl)ation. Biochem. J. 324:1997;249-253
102. Ruf A., Ménissier de Murcia J., de Murcia G., Schulz G.E. Structure of the catalytic fragment of poly(ADP-ribose) polymerase from chicken. Proc. Nat. Acad. Sci. USA. 93:1996;7481-7485
103. Ruf A., Rolli V., de Murcia G., Schulz G.E. The mechanism of the elongation and branching reaction of poly(ADP-ribose) polymerase as derive form crystal structures and mutagenesis. J. Mol. Biol. 278:1998;57-65
104. Ruscetti T., Lehnert B.E., Halbrook J., Le Trong H., Hoekstra M.F., Chen D.J., Peterson S.R. Stimulation of the DNA-dependent proteins kinase by poly(ADP-ribose)polymerase. J. Biol. Chem. 273:1998;14461-14467
105. Satoh M.S., Lindahl T. Role of poly(ADP-ribose) formation in DNA repair. Nature. 356:1992;356-358
106. Satoh M.S., Poirier G.G., Lindahl T. Dual effect for poly(ADP-ribose) synthesis in response to DNA strand breakage. Biochemistry. 33:1994;7099-7106
107. Saxena A., Saffery R., Wong L.H., Kalitsis P., Choo K.H. Centromere proteins Cenpa, Cenpb, and Bub3 interact with poly(ADP-ribose) polymerase-1 protein and are poly(ADP-ribosyl)ated. J. Biol. Chem. 277:2002;26921-26926
108. Schraufstatter I.U., Hyslop P.A., Hinshaw D.B., Spragg R.G., Sklar L.A., Cochrane C.G. Hydrogen peroxide-induced injury of cells and its prevention by inhibitors of poly(ADP-ribose) polymerase. Proc. Nat. Acad. Sci. USA. 83:1986;4908-4912
109. Schreiber V., Hunting D., Trucco C., Gowans B., Grunwald D., de Murcia G., Menissier de Murcia J. A dominant-negative mutant of human poly(ADP-ribose) polymerase affects cell recovery, apoptosis and sister chromatid exchange following DNA damage. Proc. Nat. Acad. Sci. USA. 92:1995;4753-4757
110. Seimiya H., Smith S.T. The telomeric poly(ADP-ribose) polymerase, tankyrase 1, contains multiple binding sites for telomeric repeat binding factor 1 (TRF1) and a novel acceptor, 182-kDa tankyrase-binding protein (TAB182). J. Biol. Chem. 277:2002;14116-14126
111. Shall S. ADP-ribosylation reactions. Biochimie. 77:1995;313-318
112. Shall S., de Murcia G. Poly(ADP-ribose) polymerase-1. what have we learned from the deficient mouse model? Mutat. Res. 460:2000;1-15
113. Shimokawa T., Masutani M., Nagasawa S., Nozaki T., Ikota N., Aoki Y., Nakagama H., Sugimura T. Isolation and cloning of rat poly(ADP-ribose) glycohydrolase. presence of a potential nuclear export signal conserved in mammalian orthologs J. Biochem. (Tokyo). 126:1999;748-755
114. Shiobara M., Miyazaki M., Ito H., Togawa A., Nakajima N., Nomura F., Morinaga N., Noda M. Enhanced polyadenosine diphosphate-ribosylation in cirrhotic liver and carcinoma tissues in patients with hepatocellular carcinoma. J. Gastroenterol. Hepatol. 16:2001;338-344
115. Simbulan C.-M.G., Suzuki M., Izuta S., Sakura T., Savoysky E., Kojima K., Miyahara K., Shizuta Y., Yoshida S. Poly(ADP-ribose) polymerase stimulates DNA polymerase alpha by physical association. J. Biol. Chem. 268:1993;93-99
116. Simbulan-Rosenthal C.M., Rosenthal D.S., Hilz H., Hickey R., Malkas L., Applegren N., Wu Y., Bers G., Smulson M.E. The expression of poly(ADP-ribose) polymerase during differentiation-linked DNA replication reveals that it is a component of the multiprotein DNA replication complex. Biochemistry. 35:1996;11622-11633
117. Simonin F., Höfferer L., Panzeter P.L., Muller S., de Murcia G., Althaus F.R. The carboxyl-terminal domain of human poly(ADP-ribose) polymerase. Overproduction in Escherichia coli, large scale purification, and characterization. J. Biol. Chem. 268:1993;13454-13461
118. Sims J.L., Benjamin R.C. Alteration of poly(adenosine diphosphoribose) metabolism by ethanol. mechanism of action Arch. Biochem. Biophys. 253:1987;357-366
119. Smith S. The world according to PARP. Trends Biochem. Sci. 26:2001;174-179
120. Smith S., de Lange T. Cell cycle dependent localization of the telomeric PARP, tankyrase, to nuclear pore complexes and centrosomes. J. Cell Sci. 112:1999;3649-3656
121. Smith S., de Lange T. Tankyrase promotes telomere elongation in human cells. Curr. Biol. 10:2000;1299-1302
122. Smith S., Giriat I., Schmitt A., de Lange T. Tankyrase, a poly(ADP-ribose) polymerase at human telomeres. Science (Washington, DC). 282:1998;1484-1487
123. Soriano F.G., Virag L., Jagtap P., Szabó E., Mabley J.G., Liaudet L., Marton A., Hoyt D.G., Murthy K.G., Salzman A.L., et al. Diabetic endothelial dysfunction. the role of poly(ADP-ribose) polymerase activation Nat. Med. 7:2001;108-113
124. Soriano F.G., Liaudet L., Szabó E., Virag L., Mabley J., Pacher P., Szabó C. Resistance against acute septic peritonitis in poly(ADP-ribose) polymerase deficient mice. Shock. 17:2002;286-292
125. Southan G.J., Szabó C. Poly(ADP-ribose) polymerase inhibitors. Curr. Med. Chem. 10:2003;321-340
126. Szabó C., Virag L., Cuzzocrea S., Scott G.S., Hake P., O'Connor M.P., Zingarelli B., Salzman A., Kun E. Protection against peroxynitrite-induced fibroblast injury and arthritis development by inhibition of poly(ADP-ribose) synthase. Proc. Nat. Acad. Sci. USA. 95:1998;3867-3872
127. Tentori L., Balduzzi A., Portarena I., Levati L., Vernole P., Gold B., Bonmassar E., Graziani G. Poly (ADP-ribose) polymerase inhibitor increases apoptosis and reduces necrosis induced by a DNA minor groove binding methyl sulfonate ester. Cell Death Differ. 8:2001;817-828
128. Tentori L., Portarena I., Graziani G. Potential clinical applications of poly(ADP-ribose) polymerase (PARP) inhibitors. Pharmacol. Res. 45:2002;73-85
129. Trucco C., Oliver J.F., de Murcia G., Menissier de Murcia J. DNA repair defect in poly(ADP-ribose)polymerase-deficient cell lines. Nucleic Acids Res. 26:1998;2644-2649
130. Tsai Y.J., Aoki T., Maruta H., Abe H., Sakagami H., Hatano T., Okuda T., Tanuma S. Mouse mammary tumor virus gene expression is suppressed by oligomeric ellagitannins, novel inhibitors of poly(ADP-ribose) glycohydrolase. J. Biol. Chem. 267:1992;14436-14442
131. Uchida M., Hanai S., Uematsu N., Sawamoto K., Okano H., Miwa M., Uchida K. Overexpression of poly(ADP-ribose) polymerase disrupts organization of cytoskeletal F-actin and tissue polarity in drosophila. J. Biol. Chem. 277:2001;6696-6702
132. Udea K. Poly(ADP-ribose) synthetase. Moss J., Vaughan M. ADP-ribosylating Toxins and G-proteins: Insight into Signal Transduction. 1990;525-542 American Society for Microbiology (ASM), Washington, DC
133. Ullrich O., Grune T. Proteasomal degradation of oxidatively damaged endogenous histones in K562 human leukemic cells. Free Radical Biol. Med. 31:2001;887-893
134. Ullrich O., Diestel A., Bechmann I., Homberg M., Grune T., Hass R., Nitsch R. Turnover of oxidatively damaged nuclear proteins in BV-2 microglial cells is linked to their activation state by poly ADP-ribose polymerase. FASEB J. 15:2001;1460-1462
135. van Steensel B., de Lange T. Control of telomere length by the human telomeric protein TRF1. Nature. 385:1997;740-743
136. van Steensel B., Smogorzewska A., de Lange T. TRF2 protects human telomeres from end-to-end fusions. Cell. 92:1998;401-413
137. Virág L., Szabó C. The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol. Rev. 54:2002;375-429
138. Wallis R.A., Panizzon K.L., Henry D., Wasterlain C.G. Neuroprotection against nitric oxide injury with inhibitors of ADP-ribosylation. Neuroreport. 5:1993;245-248
139. Watts J.A., Grattan R.M., Whitlow B.S., Kline J.A. Activation of poly(ADP-ribose) polymerase in severe hemorrhagic shock and resuscitation. Am. J. Physiol. Gastrointest. Liver Physiol. 281:2001;G498-G506
140. Weltin D., Marchal J., Dufour P., Potworowski E., Oth D., Bischoff P. Effect of 6(5. H)-phenanthridinone, an inhibitor of poly(ADP-ribose) polymerase, on cultured tumor cells Oncol. Res. 6:1994;399-403
141. Whalen M.J., Clark R.S., Dixon C.E., Robichaud P., Marion D.W., Vagni V., Graham S.H., Virag.L., Hasko G., Stachlewitz R., et al. Reduction of cognitive and motor deficits after traumatic brain injury in mice deficient in poly(ADP-ribose) polymerase. J. Cereb. Blood Flow Metab. 19:1999;835-842
142. Whalen M.J., Clark R.S., Dixon C.E., Robichaud P., Marion D.W., Vagni V., Graham S., Virag L., Hasko G., Stachlewitz R., et al. Traumatic brain injury in mice deficient in poly-ADP(ribose) polymerase. a preliminary report Acta Neurochir. Suppl. 76:2000;61-64
143. Whitacre C.M., Hashimoto H., Tsai M.L., Chatterjee S., Berger S.J., Berger N.A. Involvement of NAD-poly(ADP-ribose) metabolism in p53 regulation and its consequences. Cancer Res. 55:1995;3697-3701
144. Winey M. Keeping the centrosome cycle on track. Genome stability. Curr. Biol. 6:1996;962-964
145. Wu L.C., Wang Z.W., Tsan J.T., Spillman M.A., Phung A., Xu X.L., Yang M.C., Hwang L.Y., Bocock A.M., Baer R. Identification of a RING protein that can interact in vivo with the BRCA1 gene product. Nat. Genet. 14:1996;430-440
146. Zhang J., Dawson V.L., Dawson T.M., Snyder S.H. Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science (Washington, DC). 263:1994;687-689
147. Zingarelli B., Salzman A.L., Szabó C. Genetic disruption of poly(ADP-ribose) synthetase inhibits the expression of P-selectin and intercellular adhesion molecule-1 in myocardial ischemia/reperfusion injury. Circ. Res. 83:1998;85-94